EUVIMEDEUVIMED entdecken
Open Access

Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques

Whitney Rabacal iD, Anna Hu, Sara Khalife, Gina Kim, Karen A Norris

Medical Mycology · 2025

DOI: 10.1093/mmy/myaf083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Whitney Rabacal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Center for Vaccines and Immunology, University of Georgia, Athens, Georgia 30602, USA. Hauptthemen laut MEDLINE: Dexamethasone, Disease Models, Animal, Pneumonia, Pneumocystis, Pneumocystis carinii. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute for Allergy and Infectious Diseases at the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To establish an experimental model of Pneumocystis jirovecii pneumonia (PJP) in the context of drug-induced immunosuppression, cohorts of macaques were chronically treated with dexamethasone and subsequently exposed to natural transmission of Pneumocystis through co-housing with other Pneumocystis colonized or infected ‘seeder’ macaques. Through flow cytometry, we observed that long-term dexamethasone treatment reproducibly reduced the frequency and cell numbers of CD4 T cells in the peripheral blood and bronchoalveolar lavage (BAL) in both Japanese (Macaca fuscata) and rhesus macaques (Macaca mulatta), reflective of a state of chronic immunosuppression. This was accompanied by a reduction in the frequency and cell number of CD20 + B cells and the absence of antibody responses against the protective Pneumocystis antigen KEX1 in the peripheral blood. Pneumocystis-specific polymerase chain reaction and histologic evidence of Pneumocystis infection in serial BAL samples demonstrated that dexamethasone induced immunosuppression rendered both Japanese and rhesus macaques susceptible to persistent Pneumocystis colonization and subsequent infection. Moreover, disease progression was associated with increased neutrophil infiltration in the lung. Insight gained from this model will aid the development of novel prevention and treatment strategies in a highly relevant model of Pneumocystis infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneDisease Models, AnimalPneumonia, PneumocystisPneumocystis cariniiImmunocompromised HostImmunosuppressive AgentsAnimalsMacaca mulattaBronchoalveolar Lavage FluidMacaca fuscataLungCD4-Positive T-LymphocytesMaleFlow Cytometry

Stichwörter der Autor:innen

experimental modelimmunosuppressionnon-human primatepneumocystispneumocystis pneumonia

Substanzen

DexamethasoneImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Center for Vaccines and Immunology, University of Georgia, Athens, Georgia 30602, USA.
  • Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Tripoli 11-5020, Lebanon.
  • University Research Animal Resources, Office of Research, University of Georgia, Athens, Georgia 30602, USA.

ORCID-Profile: Whitney Rabacal

Förderung

  • NIAID NIH HHS
  • National Institute for Allergy and Infectious Diseases at the National Institutes of Health

Zitieren

APA

Rabacal, W., Hu, A., Khalife, S., Kim, G., & Norris, K. A. (2025). Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques. Medical Mycology. https://doi.org/10.1093/mmy/myaf083

Vancouver

Rabacal W, Hu A, Khalife S, Kim G, Norris KA. Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques. Medical Mycology. 2025. doi:10.1093/mmy/myaf083

BibTeX
@article{Rabacal2025,
  author = {Rabacal, Whitney and Hu, Anna and Khalife, Sara and Kim, Gina and Norris, Karen A},
  title = {Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques},
  journal = {Medical Mycology},
  year = {2025},
  doi = {10.1093/mmy/myaf083}
}
Kostenlos starten →